{
  "documentMetadata": {
    "title": "Endocarditis, Native Valve, Empiric Therapy",
    "lastUpdated": "2025-02-25",
    "sourceFile": "Endocarditis, Native Valve, Empiric Therapy.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Empiric therapy for native valve endocarditis pending culture results.",
        "Valvular or congenital heart disease. Signs and symptoms of endocarditis.",
        "When to start empiric therapy?",
        "If patient is not acutely ill and not in heart failure, reasonable to wait for blood culture results.",
        "If initial 3 blood cultures are negative after 24-48 hours, obtain 2-3 more blood cultures before starting empiric therapy."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staphylococcus aureus, methicillin-susceptible and methicillin-resistant strains (~30%, higher in injection drug users)",
        "Streptococcus sp. (~25%)",
        "Viridans group",
        "Streptococcus gallolyticus (formerly S. bovis)",
        "Enterococcus sp. (~10%)",
        "HACEK group organisms (~2%)",
        "Culture-negative (~10%) (usually due to prior antibiotics)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          },
          {
            "drug": "Ceftriaxone",
            "dose": "2 gm",
            "frequency": "q24h",
            "connector": "+"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL) (see Comments)"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          },
          {
            "drug": "Ciprofloxacin",
            "dose": "400 mg",
            "route": "IV",
            "frequency": "q8h",
            "connector": "+"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL) (see Comments)"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "See Clinical Setting (above) regarding when to start empiric therapy",
        "Modify therapy based on identification of specific pathogen as soon as possible to obtain best coverage and to avoid toxicities."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "There is no proven effective or preferred regimen for empirical therapy of native valve endocarditis. The regimens provided will cover the most common pathogens pending definitive identification."
      ]
    }
  ]
}
